The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between improvements in survival of metastatic NSCLC patients and targeted- and immuno-therapy.
 
Sreeram Ramagopalan
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Thomas P. Leahy
Research Funding - Advanced Accelerator Applications; Arven Pharmaceuticals; BioNTech; Bristol-Myers Squibb; F. Hoffmann LaRoche; Immunocore; Stemline Therapeutics; Vifor Pharma
 
Joshua Ray
Employment - Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Samantha Wilkinson
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Cormac J. Sammon
Research Funding - Advanced Accelerator Applications; Arven Pharmaceuticals; BioNTech; Bristol-Myers Squibb; F. Hoffmann LaRoche; Immunocore; Stemline Therapeutics; Vifor Pharma
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo; MedImmune; QED Therapeutics; R-Pharm
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape